CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The...

12
Cardio Test INFAI ® | 1 C Car Car Ca Car Car Ca Car Car Car Car ar Car Car Car Car C Ca Ca Car C Ca C Car C r Ca Ca a Ca C C Ca C Ca C C r C r C C C C C C dio dio d dio dio dio dio dio dio dio dio io o dio o o dio dio dio dio d dio dio di i i d di i i i i i i i di i d d d d d Te Te Te Te Te Te Te Te T Te Te Te Te e Te Te Te T Te Te Te Te Te Te Te e e e e e T e e e T e e T e e T T T st s s st st st t st t st st st st st st st st st s st st st st s st st s st IN IN IN N NF NF NF NF NF NF NF NF INF F F N NF NF NF I I INF INF N N NF NF N NF IN INF NF INF F AI A A AI A A A AI AI I I AI AI A AI A A A A A A AI A A A AI A A A AI I AI AI A AI A AI A AI A AI I ® ® ® ® ® ® | 1 | 1 | 1 | 1 | | | | 1 | 1 | 1 1 1 | 1 1 1 | 1 CARDIO TEST INFAI ® ...REVEALS YOUR RISK OF HEART ATTACK AND STROKE 08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 1 08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 1 19/03/2019 17:45 19/03/2019 17:45

Transcript of CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The...

Page 1: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ® | 1CCarCarCaCarCarCaCarCarCarCararCarCarCarCarCCaCaCarCCaCCarC rCaCaaCaCCCaCCaCC rC rCCCCCC diodioddiodiodiodiodiodiodiodioioodiooodiodiodiodioddiodiodiiiddiiiiiiiidiiddddd TeTeTeTeTeTeTeTeTTeTeTeTeeTeTeTeTTeTeTeTeTeTeTeeeeeeTeeeTeeTeeTTT stssstststtsttstststststststststsststststsststsst INININNNFNFNFNFNFNFNFNFINFFFNNFNFNFIIINFINFNNNFNFNNFININFNFINFFAIAAAIAAAAIAIIIAIAIAAIAAAAAAAIAAAAIAAAAIIAIAIAAIAAIAAIAAII ®®®®®® | 1| 1| 1| 1|||| 1| 1| 1 11| 1 11| 1

CARDIO TEST INFAI®

...REVEALS YOUR RISK OF HEART ATTACK AND STROKE

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 108_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 1 19/03/2019 17:4519/03/2019 17:45

Page 2: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ®2 |

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 208_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 2 19/03/2019 17:4519/03/2019 17:45

Page 3: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ® | 3

Are you reasonably worried about high cholesterol?

Yes, of course. Nowadays, almost everybody knows that high cholesterol causes arterioscle-rosis (hardening of the arteries), which constricts and obstructs the movement of blood in the vessels

and is a huge risk factor of heart and vascular diseases. Heart at-tack and stroke strike people the most today, with the number of cases and a mortality rate exceed-ing any other diseases. Cholesterol testing and monitoring have had a very positive impact on preven-tion and treatment.

Without doubt, the greatest suc-cess medicine has achieved in patient awareness over recent decades is the general knowledge of how important cholesterol is for

the health of our vessels. It was already known in ancient Greece that everyone is only as healthy as their blood vessels.

Everyone is only as healthy as their blood vessels.

Healthy bloodvessel

Vessel constrictedby atherosclerosis

Endothelium

Damagedendothelium

Fat plate (atheroma)on smooth muscle

Macrophagecells transformed

into atheromaLipids, calcium,

cell waste

Foamcells

Smooth muscle

Figure 1: Arteriosclerosis – hardening of the blood vessel.

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 308_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 3 19/03/2019 17:4519/03/2019 17:45

Page 4: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ®4 |

Cholesterol is a  lipid molecule present in every cell that is ei-ther produced by the body itself or received from food. It plays several roles and, because cho-lesterol is not soluble in water or blood, as the blood circulates it needs transport proteins to move along with other lipids. This is done by low-density and high-density lipoproteins

formed along with the choles-terol. Most of us are aware of the excess “bad cholesterol”transported by low-density li-poproteins (LDL) that builds up in blood vessels, while “good cholesterol” transported by high-density lipoproteins (HDL) helps reduce excessive choles-terol in blood and peripheral tissues.

Why is it important to know the number of LDL particles (LDL-P) and not just LDL cholesterol (LDL-C)?

Modern blood tests have en-abled scientists to discover that the lipoproteins which bind fat and cholesterol differ not only in density, but also in particle size. These particles are called LDL-P (P for particles) and tests ordi-narily used cannot identify how many there are. Today doctors

determine only the amount of cholesterol. This measurement is known as LDL-cholesterol or LDL-C. The most important thing to know for detecting the risk of heart attack and stroke is not the overall amount of cholesterol, but the number of LDL-P particles. When the number of particles is dangerously high, it elevates the risk of heart and vascular dis-eases, something proven in more than 1,000 clinical studies.

What role do cholesterol and lipoproteins play?

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 408_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 4 19/03/2019 17:4519/03/2019 17:45

Page 5: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ® | 5

Figure 2: Classification of LDL particles and cardiovascular disease risk assessment.

Why is an increased num-ber of LDL particles (LDL-P) more dangerous than LDL cholesterol (LDL-C)?

Imagine the blood flowing through your veins to be like a river and the LDL particles are boats transport-ing cholesterol and lipids as cargo. Current testing can measure the overall amount of this cargo (LDL cholesterol, triglycerides and lipids).But it is important to measure the num-

ber of boats in the river (LDL-P). A high-er number of boats and congested traf-fic along the river constitute a higher risk and danger than their cargo. So the number of LDL particles (LDL-P) more realistically reveals the risk of athero-sclerosis and cardiovascular diseases than measuring just LDL cholesterol and triglycerides. In practice, it means that people with a normal cholesterol level may have a high concentration of LDL particles (dangerously increased number of LDL-P).

High risk 

High number of largeLDL particles (LLDL-P)

Cholesterol

LDL Particle

Low risk

Low number of largeLDL particles (LLDL-P)

Lowest riskLow number of small

LDL particles (sdLDL-P)

Highest riskHigh number of small LDL particles (sdLDL-P)

Triglycerides

Assessing the risk of cardiovascular disease.

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 508_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 5 19/03/2019 17:4519/03/2019 17:45

Page 6: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ®6 |

How is a laboratoryanalysis carried out?

Blood testing is conducted at a specialized laboratory in Ger-many using NMR spectroscopy. It was for the significant contri-bution it made to science that the

inventors were awarded the Nobel Prize. This method enables the smallest particles to be analyzed quickly, precisely and reliably at the level of their individual atoms and protons. Cardio Test results are then presented in a medical report.

INFAI Cardio Test is the first and only test commercially available in Europe that assesses the in-creased risk of cardiovascular diseases. It analyzes up to 29 important parameters, using nuclear magnetic resonance (NMR) spectroscopy, to measure the number of low-density Iipo-

protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such tests that have been performed in the USA over the past decade.

Who should receivethe Cardio Test?

The test is intended mainly for people who take responsibility for their own health and seek to lead a healthy lifestyle. They are familiar with the significance of cholesterol, the danger of a high

number of LDL particles (LDL-P) and the increased risk of cardio-vascular disease associated with it. This includes up to 30% whose cholesterol levels are normal and yet the number of lipoprotein particles may be dangerously high.

What does the Cardio Test do?

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 608_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 6 19/03/2019 17:4519/03/2019 17:45

Page 7: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ® | 7

• Anyone with knowledge of heart attack or stroke in their family his-tory should be tested by the age of 30-35, irrespective of the level of cholesterol, because a genetic pre-disposition may be the cause of an increased number of LDL particles.

• Every man age 45-50 and every woman age 50-55 or at the start of menopause should be tested, even if they have a normal choles-terol level, in order to rule them out among the population facing the hidden risk of cardiovascular di-seases due to high LDL-P, some-thing ordinary testing does not detect.

• Patients being treated for elevat-ed cholesterol levels that causes undesirable side effects or when he or she seeks to minimize the side effects should be tested. Cli-nical studies have shown the LDL-P number to be more reliable and a de-cisive indicator for uncovering the risk of cardiovascular diseases than an elevated overall cholesterol level. When there is higher cholesterol and a small number of LDL-P, changing or discontinuing such treatment may be considered, especially if the patient

poorly tolerates it and he or she has not suffered a heart attack.

• Patients at increased risk of car-diovascular diseases (high blood pressure, angina pectoris, blood clotting disorders).

• Patients with diabetes and a re-duced level of cholesterol, yet have a dangerously elevated number of LDL particles.

• Patients with liver diseases.

• Patients with rheumatoid arthritis.

• Patients with renal diseases.

• Patient with thyroid gland diseases.

• Patients with retinal vascular diseases.

• Patients with symptoms of familial hypercholesterolemia (the presence of yellow cholesterol marks around the eyes or on the edge of the iris.

• Women undergoing hormone replacement therapy.

• People who smoke or are over-weight.

Who is at risk the most?

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 708_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 7 19/03/2019 17:4519/03/2019 17:45

Page 8: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ®8 |

How is the CardioTest given?

• First consult with a doctor. The Cardio Test can only be given with the cooperation of a physician, al-though his or her specialty does not matter. A current list of doctors that will let you undergo the Car-dio Test in your region is available at www.cardiotest.sk/.es/.cz and cardio-test.hu

• By agreement with your doctor, you will pay for the test (see the section below about payment). The doctor will then complete an accom-panying report and your informed

consent to testing, telling you where and when your blood will be taken.

• After your blood is drawn, a sam-ple will be processed, with the blood serum stored at -78°C and it will be transported by courier to a specialized center in Germany. There the sample will be analyzed using NMR spectroscopy.

• The test results will be issued in a medical report to be received by your doctor, who will then communicate them to you as agreed beforehand.

Consultyour doctor

01

Pay for theCardio Test

02

Have yourblood taken

and the sampleprocessed

03Samplestored and

transported04

Sampleanalyzedwith NMR

spectroscopy

05

Resultsassessed

and medicalreport issued

06

Resultsannounced

07

CARDIO TEST

COURSE OF EXAMINATION

Figure 3:Cardio Test – procedure.

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 808_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 8 19/03/2019 17:4519/03/2019 17:45

Page 9: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ® | 9

CardioTest results from your number of LDL particles (LDL-P).

Your LDL-P number is the most im-portant part of the medical report. The lower the number, the lower you are at risk of cardiovascular disease. Figure 4 shows example results from a test of the number of LDL-P particles. The identified number of particles is displayed in the white box and assesses your level of cardiovascular disease risk, as shown within the blue box.

Your LDL-P number may range from less than 1,000 to more than 2,000 nmol/l. Your LDL-P number also depends on any treatment you have undergone, such as for diabetes or a heart attack. Based on LDL-P results, your doctor will recommend the next step toward reducing a high LDL-P number and your risk of heart attack and acute stroke.

Figure 4: Cardio Test and cardiovascular disease risk assessment.

How often should theCardio Test be repeated?

• If you are under 50 years of age, good Cardio Test results will pro-vide you with a stable prognosis for about the next 5 years unless there is a significantly negative change in your lifestyle (smoking, alcohol, drugs, other disorders…)

• If you are over 50 years of age, you should undergo the Cardio

Test at least every 3 years, if there is no major change in your life-style.

• If your doctor tells you that the test results necessitate the start of adjustment of treatment, it is advisable to repeat the Cardio Test more often in order to as-sess how effective the therapy has been. This always depends on your doctor’s recommenda-tions.

LDL-Pnmol/l

1,473normal

below 1,000lowrisk

1,000 – 1,299moderate

– increased risk

1,300 – 1,599highrisk

1,600 – 2,000very high

risk

above 2,000Number of LDL particles

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 908_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 9 19/03/2019 17:4519/03/2019 17:45

Page 10: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ®10 |

How to pay for testing.

Cardio Test is not covered by mandatory public health insurance.

Each test costs € 300, without VAT.

The price for a Cardio Test includes the entire examination but if the blood sample is taken and serum processed in an independent

laboratory, there is an extra charge for it.

Current details about payment methods can be found at:www.cardiotest.skwww.cardiotest.czwww.cardiotest.es

www.cardio-test.hu

If any sample is damaged, another sample will be taken.There is no charge for such a sample.

Cardio Test INFAI ® is carried out in cooperation withNumares and Allmedical.

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 1008_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 10 19/03/2019 17:4519/03/2019 17:45

Page 11: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

Cardio Test INFAI ® | 11

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 1108_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 11 19/03/2019 17:4519/03/2019 17:45

Page 12: CARDIO TEST INFAI · protein fraction particles (LDL-P), something no ordinary test can do. The significance of LDL parti-cle testing is evident in the more than 16 million of such

www.cardiotest.skwww.cardiotest.czwww.cardiotest.eswww.cardio-test.hu

08_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 1208_CTI_CARDIO_PACIENTI_EN_08_PRESS.indd 12 19/03/2019 17:4519/03/2019 17:45